News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No major news published in the past hour, leaving markets without fresh directional catalysts.
  • Equity markets remained quiet amid sparse headlines and thin trading interest.
  • No notable macro data or central bank statements were released during the hour.
  • No new geopolitically material developments were reported.
  • Oil and FX markets were subdued without fresh supply or policy drivers.
  • Corporate newsflow was inactive with no major earnings or M&A announcements.

Latest Articles

U.S. Futures Tick Higher After Mixed Inflation, Slower GDP and Firm Jobless Claims

U.S. Futures Tick Higher After Mixed Inflation, Slower GDP and Firm Jobless Claims

U.S. stock index futures rose modestly on July 30 as investors parsed June inflation data, an advance estimate of second-quarter GDP and weekly unemployment claims. The Commerce Department reported the Personal Consumption Expenditures Price index fell 0.1% in June, with the annual rate at 3.7%. Core PCE rose 0.1% month-on-month and 3.3% year-on-ye…

Terex Shares Jump After Strong Q2 Results and Upgraded Full-Year Outlook

Terex Shares Jump After Strong Q2 Results and Upgraded Full-Year Outlook

Terex Corporation opened higher in pre-market trading after posting second-quarter 2026 results that exceeded analyst expectations on both revenue and earnings. Management raised its full-year outlook, forecasting about 7% pro forma sales growth to $7.9 billion-$8.2 billion and a 14.5% increase in Adjusted EBITDA to $960 million-$1.0 billion. The b…

Braveheart Bio files to raise $318.8M in IPO for cardiac myosin inhibitor

Braveheart Bio files to raise $318.8M in IPO for cardiac myosin inhibitor

Braveheart Bio Inc., a San Francisco-based clinical-stage biopharmaceutical company backed by a16z, has filed to raise up to $318.8 million in an initial public offering. The company is offering 18.8 million shares at $15 to $17 apiece, which would value Braveheart at roughly $1.2 billion at the top of the range. Proceeds are tied to advancing BHB-…

Alnylam Shares Tumble After Q2 Revenue Miss and Large Guidance Cut

Alnylam Shares Tumble After Q2 Revenue Miss and Large Guidance Cut

Alnylam Pharmaceuticals plunged in pre-market trading after reporting second-quarter 2026 results that missed revenue expectations and prompted a substantial downward revision to full-year guidance. Management said the outlook change reflects a normalization of second-line patient volumes in the ATTR-CM market following the initial launch surge for…

Ukraine's National Bank hikes policy rate to 15.5% as inflation pressures mount

Ukraine's National Bank hikes policy rate to 15.5% as inflation pressures mount

The National Bank of Ukraine raised its key interest rate by 50 basis points to 15.5%, the first hike since March 2025. The move responds to accelerating core inflation and a restart in headline price pressures, and is intended to support the hryvnia, stabilize foreign-exchange markets and anchor inflation expectations as the economy shows modest g…

Barclays Backs L'Oréal and Unilever on Premium Beauty Demand and Innovation

Barclays Backs L'Oréal and Unilever on Premium Beauty Demand and Innovation

Barclays identified L'Oréal and Unilever as its preferred holdings within European consumer staples, citing sustained demand for premium beauty, accelerating cosmetics consumption globally and the strategic advantage of product innovation combined with focused brand investment. The bank singled out L'Oréal as its clearest preferred name due to robu…

Braveheart Bio Seeks Up to $1.2 Billion Valuation in U.S. IPO

Braveheart Bio Seeks Up to $1.2 Billion Valuation in U.S. IPO

Braveheart Bio filed to go public in the United States seeking a valuation of as much as $1.2 billion. The San Francisco-based clinical-stage company plans to offer 18.8 million shares at $15 to $17 each to raise $318.8 million, with plans to use proceeds to further develop its lead candidate BHB-1893 and support R&D and corporate needs.

20/20 BioLabs to Host Investor Webinar on August 5, 2026, to Discuss Commercial Opportunities Following Management’s Recent East Asia Business Development Tour

20/20 BioLabs to Host Investor Webinar on August 5, 2026, to Discuss Commercial Opportunities Following Management’s Recent East Asia Business Development Tour

20/20 BioLabs announced an investor webinar to discuss its recent East Asia business development tour involving meetings in Taipei, Tokyo, and Seoul, participation in BIO Asia-Taiwan, and its roll-up strategy including potential mergers, acquisitions, partnerships, and licensing opportunities. The company aims to leverage these relationships to exp…

Phunware Announces Key Appointments Following Successful HITEC Industry Conference; Expansion of AI Concierge Footprint

Phunware Announces Key Appointments Following Successful HITEC Industry Conference; Expansion of AI Concierge Footprint

Phunware, Inc. announced key executive appointments and advisory additions to accelerate commercial growth and expand its AI-enabled Guest Intelligence Platform in hospitality and healthcare sectors. Following successful demonstrations at HITEC 2026, the company secured new client agreements and is positioned to further scale its mobile-first enter…

BTIG Elevates Take-Two to Top Pick Ahead of Grand Theft Auto VI Debut

BTIG Elevates Take-Two to Top Pick Ahead of Grand Theft Auto VI Debut

BTIG has named Take-Two Interactive a top pick, reiterating an Outperform rating and assigning a $285 price target as the studio prepares to launch Grand Theft Auto VI on November 19. The brokerage is forecasting substantial bookings for fiscal 2027, driven primarily by GTA VI unit sales and premium pricing assumptions, while flagging unanswered qu…

G10 banks tread carefully as markets price in energy and AI risks

G10 banks tread carefully as markets price in energy and AI risks

Global central banks in the Group of 10 have adopted a cautious approach to policy tightening, holding many rates steady while markets weigh the inflationary implications of rising energy prices and uncertain effects from accelerated investment in AI. The Federal Reserve's decision to pause, accompanied by mixed signals from its leadership, sparked…

Lite Strategy Repurchases 13% of Outstanding Shares Since December, Increasing Litecoin Backing Per Share

Lite Strategy Repurchases 13% of Outstanding Shares Since December, Increasing Litecoin Backing Per Share

Lite Strategy, Inc. announced it repurchased approximately 4.9 million shares (13% of outstanding) from December 2025 to July 2026, using $5.4 million from active treasury operations. Shares were bought at a significant discount to net asset value (NAV) of its Litecoin holdings, effectively increasing the Litecoin backing per share and narrowing th…